Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

The Africa Centers for Disease Control and Prevention (Africa CDC) declared a public health emergency earlier this ... remains the only recognised drug treatment for mpox – there are three ...

A wet weather pattern returns to the Bay Area as an atmospheric river system arrives Wednesday. Showers are possible on Thursday, with another weather system arriving Friday. Paul Heggen has the ...

Here's the latest news and everything you need to know about the first major wave of NFL player movement this spring. The new league year is here, and the deals are nowhere near done. Stay updated ...

A new video that helps producers and veterinarians understand new sampling and testing procedures for drug residues in milk and meat, and features tools that can help them avoid a residue violation is ...

Reproxalap, a first-in-class small-molecule modulator of reactive aldehyde species (RASP), is under review for the treatment of the signs and symptoms of dry eye disease. It works by covalently ...

For patients receiving an emergency department initiation, the continuation ratio to receive a second prescription within 40 days was 2.8. (HealthDay News) — Emergency clinicians in California ...

At close: March 12 at 4:00:00 p.m. EDT ...

The approval is only for the 2.5mg tablet. Xarelto is also available in 10mg, 15mg, and 20mg tablets, as well as an oral suspension (1mg/mL), to treat various conditions. In a statement, the FDA noted ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...